About

Antonio Costa, PhD, is the Chief Executive Officer of DIANT Pharma and has been involved with continuous processing of lipid and polymer nanoparticle formulations for over seven years. With his multidisciplinary background, he has been a key figure in the design and development of the continuous processing technology at the University of Connecticut (Storrs, CT, US). Dr Costa is the named inventor on two patents and multiple patent applications and the author of several peer-reviewed publications.

Top